KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Dynavax Technologies (DVAX) over the last 17 years, with Q3 2025 value amounting to $647.8 million.

  • Dynavax Technologies' Cash & Current Investments fell 1520.66% to $647.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $647.8 million, marking a year-over-year decrease of 1520.66%. This contributed to the annual value of $713.8 million for FY2024, which is 383.51% down from last year.
  • Per Dynavax Technologies' latest filing, its Cash & Current Investments stood at $647.8 million for Q3 2025, which was down 1520.66% from $613.7 million recorded in Q2 2025.
  • Over the past 5 years, Dynavax Technologies' Cash & Current Investments peaked at $764.0 million during Q3 2024, and registered a low of $232.7 million during Q1 2021.
  • Its 5-year average for Cash & Current Investments is $601.4 million, with a median of $647.8 million in 2025.
  • Per our database at Business Quant, Dynavax Technologies' Cash & Current Investments surged by 23080.66% in 2021 and then crashed by 1656.89% in 2025.
  • Quarter analysis of 5 years shows Dynavax Technologies' Cash & Current Investments stood at $545.9 million in 2021, then rose by 14.37% to $624.4 million in 2022, then grew by 18.88% to $742.3 million in 2023, then fell by 3.84% to $713.8 million in 2024, then dropped by 9.25% to $647.8 million in 2025.
  • Its Cash & Current Investments stands at $647.8 million for Q3 2025, versus $613.7 million for Q2 2025 and $661.3 million for Q1 2025.